The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Laliberte Kevin since 2017.
The trader's CIK number is 1709417.
At the time of the last reporting, Laliberte Kevin was the Sr. VP, Product Development of Dova Pharmaceuticals Inc.. (stock ticker symbol DOVA).
Also see all insider trading activities at Dova Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | DOVA | 0 | $0 | 9,376 | $204,546 | 0 | $0 |
| 2017 | DOVA | 6,200 | $105,400 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-09-30 | DOVA | Sale | 3,696 | 28.00 | 103,488 |
| 2019-09-25 | DOVA | Sale | 3,100 | 20.00 | 62,000 |
| 2019-07-31 | DOVA | Sale | 1,389 | 15.97 | 22,182 |
| 2019-07-01 | DOVA | Sale | 1,191 | 14.17 | 16,876 |
| 2017-07-05 | DOVA | Buy | 6,200 | 17.00 | 105,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Laliberte Kevin (Sr. VP, Product Development of Dova Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.